Cardiopulmonary effects of antimalarial drugs. V. Cycloguanil and a new triazine compound (WR 99,662).
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000633:toxicity*; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D005260:Female; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007928:Lethal Dose 50; D002955:Leucovorin / Q000494:pharmacology; D008168:Lung / Q000187:drug effects; D008297:Male; D051379:Mice; D009026:Mortality; D011011:Pneumoencephalography; D002727:Proguanil / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012156:Reticulocytes / Q000187:drug effects; D013045:Species Specificity; D014227:Triazines / Q000633:toxicity*
D000319:Adrenergic beta-Antagonists; D000962:Antimalarials; D014227:Triazines; D012110:Reserpine; D002955:Leucovorin; D002727:Proguanil